PART 212—CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS
- SUBPART A—General Provisions (§212.1 to §212.5)
- SUBPART B—Personnel and Resources (§212.10 to §212.10)
- SUBPART C—Quality Assurance (§212.20 to §212.20)
- SUBPART D—Facilities and Equipment (§212.30 to §212.30)
- SUBPART E—Control of Components, Containers, and Closures (§212.40 to §212.40)
- SUBPART F—Production and Process Controls (§212.50 to §212.50)
- SUBPART G—Laboratory Controls (§212.60 to §212.61)
- SUBPART H—Finished Drug Product Controls and Acceptance (§212.70 to §212.71)
- SUBPART I—Packaging and Labeling (§212.80 to §212.80)
- SUBPART J—Distribution (§212.90 to §212.90)
- SUBPART K—Complaint Handling (§212.100 to §212.100)
- SUBPART L—Records (§212.110 to §212.110)